Product Center
Yisuda®Suraxavir Marboxil Tablets
Yisuda®Suraxavir Marboxil Tablets are a novel antiviral medication for the treatment of uncomplicated influenza A and B in previously healthy adolescents aged 12 and above, and adults.
Aurantii® Fructus Immaturus Total Flavonoids Tablet
Aurantii® Fructus Immaturus Total Flavonoids Tablet have good therapeutic effects on common symptoms of functional dyspepsia (such as liver-stomach disharmony, spleen-stomach damp-heat, food stagnation, and spleen-stomach deficiency).
Xiyanping Injection
Xiyanping Injection is a traditional Chinese medicine injection made from total sulfated andrographolide, a key component of Andrographis paniculata. It is part of the National “12th Five-Year Plan” Major Innovative Drug Discovery Project.
Qingruitan®Brivaracetam Tablets
Brivaracetam is an innovative third-generation antiepileptic drug that selectively targets synaptic vesicle protein 2A (SV2A) with high affinity.
Bangkaxin®Esomeprazole Magnesium Enteric-coated Tablets
Bangkaxin® Esomeprazole Magnesium Enteric-coated Tablets are a new generation of proton pump inhibitors (PPIs), approved as a Class 4 chemical drug. It is the only esomeprazole magnesium enteric-coated tablet in China that is bioequivalent to the original brand. It is clinically used for the prevention and treatment of acid-related diseases such as gastroesophageal reflux disease (GERD), peptic ulcers, stress ulcers, Helicobacter pylori eradication, and drug-induced gastric mucosal injury. It is widely used in clinical practice and is a first-line choice for acid suppression therapy and ulcer prevention and treatment.
Zebeining® Palbociclib Capsuless
Zebeining® Palbociclib Capsuless are an oral CDK4/6 inhibitor that selectively targets and inhibits the activity of the CDK4/6-Cyclin D1 complex. This prevents tumor cells from passing through the G1 to S phase checkpoint, blocking the cell cycle and inhibiting tumor cell proliferation.It is primarily used for the treatment of hormone receptor-positive (HR+), HER2-negative locally advanced or metastatic breast cancer, in combination with aromatase inhibitors as initial endocrine therapy for postmenopausal women.
Ningbituo® Tofacitinib Citrate Tablets
Tofacitinib is an oral selective Janus kinase (JAK) inhibitor, a targeted immunosuppressant. JAK is an intracellular enzyme that transmits signals generated by the interaction of cytokines and receptors on the cell membrane. Within the signaling pathway, JAK phosphorylates and activates signal transcription factors and transcriptional activators (STAT), thereby regulating gene expression and cytokine production.
Shikang® Apixaban Tablets
Shikang® Apixaban Tablets are an oral, potent, and highly selective direct Factor Xa inhibitor.
Qingfeng® Shanxiangyuan Series Products
Qingfeng®Shanxiangyuan Series Products is based on a traditional Hakka herbal formula, available in tablets, lozenges, and granules.
Qingfeng® Antiviral Oral Solution
Qingfeng® Antiviral Oral Solution is made from carefully selected authentic herbs, known for clearing heat, removing dampness, cooling blood, and detoxifying.
Qingluoning® Atomoxetine Hydrochloride Oral Solution
Qingluoning® Atomoxetine Hydrochloride Oral Solution is clinically used for the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) in children and adolescents aged six years and older.
Xinkun® Mecobalamin Tablets
Xinkun® Mecobalamin Tablets are a neurotrophic repair agent that effectively repairs damaged nerves and alleviates numbness and pain. It is clinically used to treat peripheral neuropathy, showing significant effects on Wallerian degeneration, axonal degeneration, and segmental demyelination.
Bangweixin® Rabeprazole Sodium Enteric-Coated Tablets
Bangweixin® Rabeprazole Sodium Enteric-Coated Tablets are developed based on the concept of Quality by Design (QbD) and using systematic, scientific, and rigorous experimental design methods. This ensures the safety, efficacy, and controllability of the drug quality.
Ningbeituo® Urapidil Hydrochloride Injection
Ningbeituo® Urapidil Hydrochloride Injection is a selective α1-adrenergic receptor antagonist that exerts both central and peripheral blood pressure-lowering effects.
